259 related articles for article (PubMed ID: 20516071)
1. Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of action.
Ouertatani-Sakouhi H; El-Turk F; Fauvet B; Cho MK; Pinar Karpinar D; Le Roy D; Dewor M; Roger T; Bernhagen J; Calandra T; Zweckstetter M; Lashuel HA
J Biol Chem; 2010 Aug; 285(34):26581-98. PubMed ID: 20516071
[TBL] [Abstract][Full Text] [Related]
2. A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor.
Ouertatani-Sakouhi H; El-Turk F; Fauvet B; Roger T; Le Roy D; Karpinar DP; Leng L; Bucala R; Zweckstetter M; Calandra T; Lashuel HA
Biochemistry; 2009 Oct; 48(41):9858-70. PubMed ID: 19737008
[TBL] [Abstract][Full Text] [Related]
3. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MIF bioactivity by rational design of pharmacological inhibitors of MIF tautomerase activity.
Dios A; Mitchell RA; Aljabari B; Lubetsky J; O'Connor K; Liao H; Senter PD; Manogue KR; Lolis E; Metz C; Bucala R; Callaway DJ; Al-Abed Y
J Med Chem; 2002 Jun; 45(12):2410-6. PubMed ID: 12036350
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Senter PD; Al-Abed Y; Metz CN; Benigni F; Mitchell RA; Chesney J; Han J; Gartner CG; Nelson SD; Todaro GJ; Bucala R
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):144-9. PubMed ID: 11773615
[TBL] [Abstract][Full Text] [Related]
6. Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.
Bloom J; Metz C; Nalawade S; Casabar J; Cheng KF; He M; Sherry B; Coleman T; Forsthuber T; Al-Abed Y
J Biol Chem; 2016 Dec; 291(51):26502-26514. PubMed ID: 27793992
[TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments.
Garai J; Lóránd T
Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614
[TBL] [Abstract][Full Text] [Related]
8. A novel allosteric inhibitor of macrophage migration inhibitory factor (MIF).
Bai F; Asojo OA; Cirillo P; Ciustea M; Ledizet M; Aristoff PA; Leng L; Koski RA; Powell TJ; Bucala R; Anthony KG
J Biol Chem; 2012 Aug; 287(36):30653-63. PubMed ID: 22782901
[TBL] [Abstract][Full Text] [Related]
9. Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.
Orita M; Yamamoto S; Katayama N; Aoki M; Takayama K; Yamagiwa Y; Seki N; Suzuki H; Kurihara H; Sakashita H; Takeuchi M; Fujita S; Yamada T; Tanaka A
J Med Chem; 2001 Feb; 44(4):540-7. PubMed ID: 11170644
[TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor and the discovery of tautomerase inhibitors.
Orita M; Yamamoto S; Katayama N; Fujita S
Curr Pharm Des; 2002; 8(14):1297-317. PubMed ID: 12052220
[TBL] [Abstract][Full Text] [Related]
11. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
[TBL] [Abstract][Full Text] [Related]
12. The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor.
El-Turk F; Cascella M; Ouertatani-Sakouhi H; Narayanan RL; Leng L; Bucala R; Zweckstetter M; Rothlisberger U; Lashuel HA
Biochemistry; 2008 Oct; 47(40):10740-56. PubMed ID: 18795803
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel Inhibitors of the Tautomerase Activity of Macrophage Migration Inhibitory Factor (MIF).
Zapatero MC; Pérez P; Vázquez MJ; Colmenarejo G; de Los Frailes M; Ramón F
J Biomol Screen; 2016 Jun; 21(5):446-58. PubMed ID: 26933127
[TBL] [Abstract][Full Text] [Related]
14. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
[TBL] [Abstract][Full Text] [Related]
15. Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
Crichlow GV; Lubetsky JB; Leng L; Bucala R; Lolis EJ
Biochemistry; 2009 Jan; 48(1):132-9. PubMed ID: 19090677
[TBL] [Abstract][Full Text] [Related]
16. Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.
Trivedi-Parmar V; Jorgensen WL
J Med Chem; 2018 Sep; 61(18):8104-8119. PubMed ID: 29812929
[TBL] [Abstract][Full Text] [Related]
17. MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Al-Abed Y; VanPatten S
Future Med Chem; 2011 Jan; 3(1):45-63. PubMed ID: 21428825
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor.
Bendrat K; Al-Abed Y; Callaway DJ; Peng T; Calandra T; Metz CN; Bucala R
Biochemistry; 1997 Dec; 36(49):15356-62. PubMed ID: 9398265
[TBL] [Abstract][Full Text] [Related]
19. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
20. Current developments of macrophage migration inhibitory factor (MIF) inhibitors.
Xu L; Li Y; Sun H; Zhen X; Qiao C; Tian S; Hou T
Drug Discov Today; 2013 Jun; 18(11-12):592-600. PubMed ID: 23466524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
